JTJay Thakkar

Jay Thakkar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jay Thakkar has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic performance of magnetic resonance imaging (MRI) in patients with operable cervical cancer: a retrospective analysis

    by Rohini Kulkarni, Jay Thakkar, Meenakshi Thakur, Kedar Deodhar, Pabashi Poddar, Amita Maheshwari

    Kulkarni R, et al. J Gynecol Oncol. 2022 Aug;33(Suppl 1):S14. https://doi.org/10.3802/jgo.2022.33.S14

  • Open Access

    Design Considerations in Development of a Mobile Health Intervention Program: The TEXT ME and TEXTMEDS Experience

    by Jay Thakkar, Tony Barry, Aravinda Thiagalingam, Julie Redfern, Alistair L McEwan, Anthony Rodgers, Clara K Chow

    Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.


  • Open Access

    Factors Influencing Engagement, Perceived Usefulness and Behavioral Mechanisms Associated with a Text Message Support Program

    by Julie Redfern, Karla Santo, Genevieve Coorey, Jay Thakkar, Maree Hackett, Aravinda Thiagalingam, Clara K Chow

    Many studies have now demonstrated the efficacy of text messaging in positively changing behaviours. We aimed to identify features and factors that explain the effectiveness of a successful text messaging program in terms of user engagement, perceived usefulness, behavior change and program delivery preferences. Mixed methods qualitative design combining four data sources; (i) analytic data extracted directly from the software system, (ii) participant survey, (iii) focus groups to identify barriers and enablers to implementation and mechanisms of effect and (iv) recruitment screening logs and text message responses to examine engagement. This evaluation was conducted within the TEXT ME trial—a parallel design, single-blind randomized controlled trial (RCT) of 710 patients with coronary heart disease (CHD). Qualitative data were interpreted using inductive thematic analysis. 307/352 (87% response rate) of recruited patients with CHD completed the program evaluation survey at six months and 25 participated in a focus group. Factors increasing engagement included (i) ability to save and share messages, (ii) having the support of providers and family, (iii) a feeling of support through participation in the program, (iv) the program being initiated close to the time of a cardiovascular event, (v) personalization of the messages, (vi) opportunity for initial face-to-face contact with a provider and (vii) that program and content was perceived to be from a credible source. Clear themes relating to program delivery were that diet and physical activity messages were most valued, four messages per week was ideal and most participants felt program duration should be provided for at least for six months or longer. This study provides context and insight into the factors influencing consumer engagement with a text message program aimed at improving health-related behavior. The study suggests program components that may enhance potential success but will require integration at the development stage to optimize up-scaling. Australia and New Zealand Clinical Trials Registry, ACTRN12611000161921.


  • Open Access

    Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial

    by Jay Thakkar, Julie Redfern, Aravinda Thiagalingam, Clara K Chow

    Background. Mobile phone text message interventions are used to support behaviour change including physical activity, but we have less insight into how


  • Text Messaging and Medication Adherence—Do We Have a Missed Call?—Reply

    by Jay Thakkar, Julie Redfern, Clara K. Chow

    In Reply It is well known that nonadherence to therapies in chronic diseases is associated with increased morbidity, mortality, and health care costs.1 Poor adherence is known to result from an interplay of multiple factors related to patient, therapy, and health care system.2 Key factors affecting adherence include motivation, forgetfulness, adverse effects, cost of therapy, complexity of regimen, and patient beliefs about disease or therapy.


  • Open Access

    Development of macaronic Hindi-English ‘Hinglish’ text message content for a coronary heart disease secondary prevention programme

    by Jay Thakkar, Ganesan Karthikeyan, Gaurav Purohit, Swetha Thakkar, Jitender Sharma, Sunilkumar Verma, Neeraj Parakh, Sandeep Seth, Sundeep Mishra, Rakesh Yadav, et al.

    Background Coronary heart disease (CHD) is a leading cause of morbidity and mortality in India. Text message based prevention programs have demonstrated reduction in cardiovascular risk factors among patients with CHD in selected populations. Customisation is important as behaviour change is influenced by culture and linguistic context. Objectives To customise a mobile phone text message program supporting behaviour and treatment adherence in CHD for delivery in North India. Methods We used an iterative process with mixed methods involving three phases: (1) Initial translation, (2) Review and incorporation of feedback including review by cardiologists in India to assess alignment with local guidelines and by consumers on perceived utility and clarity and (3) Pilot testing of message management software. Results Messages were translated in three ways: symmetrical translation, asymmetrical translation and substitution. Feedback from cardiologists and 25 patients was incorporated to develop the final bank. Patients reported Hinglish messages were easy to understand (93%) and useful (78%). The software located in Australia successfully delivered messages to participants based in Delhi-surrounds (India). Conclusions Our process for customisation of a text message program considered cultural, linguistic and the medical context of potential participants. This is important in optimising intervention fidelity across populations enabling examination of the generalisability of text message programs across populations. We also demonstrated the customised program was acceptable to patients in India and that a centralised cross-country delivery model was feasible. This process could be used as a guide for other groups seeking to customise their programs. Trial registration number TEXTMEDS Australia (Parent study)—ACTRN 12613000793718.


  • Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials

    by Karla Santo, Suzanne Kirkendall, Tracey-Lea Laba, Jay Thakkar, Ruth Webster, John Chalmers, Clara K Chow, Julie Redfern

    Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.


  • Targeted Text Messaging Support for Patients With Coronary Heart Disease—Reply

    by Jay Thakkar, Julie Redfern, Clara K. Chow, For the TEXT ME Investigators

    In Reply The TEXT ME study was a randomized clinical trial designed to evaluate the effects of a mobile phone text messaging support program in addition to the standard secondary preventive care offered to patients with coronary heart disease. The primary outcome of the study was level of plasma LDL-C at 6 months, and the trial was designed to study the mean difference between the intervention and control group at that point. We used analysis of covariance to analyze outcomes with the baseline values as covariates1; analysis of variance of change from baseline was not used in any of the analyses. This is explained in footnote 2 of the end points table (Table 2 in the article), and the statistical comparisons in this table refer to the differences between the 2 randomized groups at 6 months, rather than change within a particular group from baseline.


  • Top Cited Papers
    Open Access

    Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease

    by Jay Thakkar, Rahul Kurup, Tracey-Lea Laba, Karla Santo, Aravinda Thiagalingam, Anthony Rodgers, Mark Woodward, Julie Redfern, Clara K. Chow

    Adherence is defined as the extent to which a patient correctly follows a prescribed therapy. Adherence is the medically preferred term because it reflects active involvement of the patient and a therapeutic alliance between the patient and his or her physician.1 This term is in contrast to compliance, which reflects more unidirectional connotations.1,2 Adherence to long-term therapies in developed countries is typically reported to be approximately 50% at 1 year after initiation of therapy, with worse rates in lower socioeconomic groups and in developing countries.3,4 Poor adherence has been linked to successive hospitalizations, increased need for medical interventions, morbidity, and mortality.5 In addition, medication nonadherence results in increased health care cost, with estimates from North America of approximately $100 billion being spent annually and $2000 spent per patient per year in excess physician visits.6


  • Inaccurate risk perceptions contribute to treatment gaps in secondary prevention of cardiovascular disease

    by J. Thakkar, E. L. Heeley, J. Chalmers, C. K. Chow

    Background: All patients with cardiovascular disease (CVD) are at high risk of recurrent events. Despite strong evidence, large treatment gaps exist in CVD secondary prevention. We hypothesise that patients' self‐perception and general practitioner's (GP) assessment of future cardiovascular (CV) risk may influence secondary prevention behaviours.Aim: To examine in patients with known CVD the perceived risk of future CV events and its relationship with use of secondary prevention medications and risk factor control.Methods: We examined patient and practitioner's perceived risk and its relationship with the uptake of secondary prevention recommendations in adults with CVD participating in the Australian Hypertension and Absolute Risk Study.Results: Among the 1453 participants, only 11% reported having a high absolute risk and 29% reported high relative risk of recurrent events. The GP categorised only 30% as having a 5‐year risk ≥15%. After adjusting for covariates, hospitalisation within the preceding 12 months was the only significant predictor of patients' accurate risk perception. Conventional CV risk factors were predictive of the GP’s risk estimates. Patients who accurately understood their risk reported higher smoking cessation rates (7 vs 3%, P = 0.003) and greater use of antiplatelet, blood pressure lowering therapy and statins (P ≤ 0.01). However, there was no relationship between GP’s risk perception and secondary prevention treatments.Conclusion: Both patients and GP have optimistic bias and underestimate the risk of future CV events. Patients' accurate self‐perception, but not GP risk perception, was associated with improved secondary preventative behaviours. This suggests that helping patients to understand their risk may influence their motivation towards secondary prevention. Providing support to GP or programmes to help patients better understand their risks could have potential benefit on secondary prevention behaviours.